Stock ENTREMED INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar EntreMed Inc Nasdaq

Equities

US29382F2020

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for EntreMed Inc
28/03 CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
05/03 Top Midday Gainers MT

Chart calendar EntreMed Inc

3d213a70e6d9b3be54e607d120bb98a.fnIo-UD2ICgS2EaJeqa7JsJHi2F5LHIsbMesNwane3g.HTMaoxOPaR8ksyq9I8-MVYBw6C0AdAtPWpKcTmPxTRQVOUWeFI5LWiaZKQ~444b88b87824346e774b249c2429f209

Upcoming events on EntreMed Inc

20/05/2024 Q1 2024 Earnings Release
09/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
23/04/2025 Q4 2024 Earnings Release (Projected)
14/05/2025 Q1 2025 Earnings Release (Projected)

Past events on EntreMed Inc

28/03/2024 04:30 pm Q4 2023 Earnings Release
14/11/2023 05:30 pm Q3 2023 Earnings Release
11/08/2023 04:30 pm Q2 2023 Earnings Release
17/05/2023 Q1 2023 Earnings Release
26/04/2023 Q4 2022 Earnings Release
14/11/2022 05:30 pm Q3 2022 Earnings Release
12/08/2022 05:30 pm Interim 2022 Earnings Call
12/08/2022 04:30 pm Interim 2022 Earnings Release
02/06/2022 Reverse Split: 1 of 10
25/05/2022 06:30 pm Annual General Meeting
12/05/2022 05:30 pm Q1 2022 Earnings Call
12/05/2022 04:30 pm Q1 2022 Earnings Release
28/03/2022 05:30 pm FY 2021 Earnings Call
28/03/2022 04:30 pm FY 2021 Earnings Release
12/12/2021 04:00 am American Society of Hematology Virtual Meeting and Exposition
18/11/2021 Jefferies London Healthcare Conference
12/11/2021 06:30 pm Q3 2021 Earnings Call
12/11/2021 05:30 pm Q3 2021 Earnings Release
21/09/2021 09:35 pm Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
12/08/2021 05:30 pm Interim 2021 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		4,13
7,82
-47.16%		15,1
14,7
3.05%		30,2
30,1
0.29%		43,1
38,7
11.51%		33,9
36,4
-6.97%
59,2

EBITDA
Million USD		Released
Forecast
Spread 		-32,2
-32,1
-0.3%		-31,7
-32,4
1.91%		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-40,0
-37,8
-5.75%		-33,7
-39,8
15.24%		-41,8
-37,6
-11.12%		-34,0
-27,6
-23.26%		-25,1
-25,1
-0%
0,05

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-45,4
-40,4
-12.36%		-47,5
-39,9
-19.05%		-35,8
-37,9
5.44%		-37,4
-27,3
-37.08%		-26,3
-25,6
-2.52%
0,05

Net income
Million USD		Released
Forecast
Spread 		-46,0
-40,9
-12.54%		-48,3
-41,7
-15.71%		-36,7
-42,2
13.09%		-41,0
-26,5
-55.02%		-27,0
-26,0
-3.54%
0,04

EPS
USD		Released
Forecast
Spread 		-4,80
-4,14
-15.97%		-4,40
-3,79
-16.24%		-2,70
-3,03
10.99%		-3,01
-1,65
-82.42%		-2,02
-1,93
-4.66%
0,00

Announcement Date16/03/2030/03/2128/03/2226/04/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		9,16
9,06
1.13%		9,06
9,24
-1.96%		8,57
7,87
8.91%		10,2
9,91
3.05%		15,3
10,8
41.18%		8,35
9,10
-8.27%		9,82
10,1
-2.68%		8,84
10,4
-15.25%		6,87
9,41
-26.97%
12,0


13,8


15,5


17,8

EBIT
Million USD		Released
Forecast
Spread 		-11,4
-7,20
-58.85%		-7,29
-13,1
44.24%		-7,75
-9,46
18.12%		-6,35
-7,61
16.54%		-12,6
-6,22
-103.21%


-9,35
-6,84
-36.7%		-5,10
-7,66
33.5%		-3,43
-3,26
-5.19%











Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-4,79
-7,10
32.54%		-8,40
-12,0
29.88%		-7,49
-8,73
14.18%		-5,02
-6,88
27.03%		-16,5
-5,23
-216.02%


-10,1
-6,84
-47.09%		-4,45
-7,66
41.91%		-5,97
-3,26
-83.3%











Net income
Million USD		Released
Forecast
Spread 		-5,60
-8,30
32.52%		-8,60
-12,1
28.75%		-7,68
-8,79
12.6%		-5,20
-6,93
24.92%		-19,5
-5,25
-272.42%


-10,2
-6,84
-49.78%		-4,64
-7,66
39.51%		-6,08
-3,26
-86.53%











EPS
USD		Released
Forecast
Spread 		-0,40
-0,57
29.41%		-0,60
-0,87
30.77%		-0,56
-0,64
12.5%		-0,38
-0,46
17.99%		-1,44
-0,37
-289.19%		-0,45
-0,64
29.69%		-0,77
-0,50
-54%		-0,35
-0,56
37.5%		-0,46
-0,24
-91.67%
-0,05


-0,01


0,01


0,03

Announcement Date28/03/2212/05/2212/08/2214/11/2226/04/2317/05/2311/08/2314/11/2328/03/24----

Upcoming sector events for EntreMed Inc

13/05/2024 PHARMANUTRA S.P.A.: Q1 2024 Earnings Release
13/05/2024 AARTI PHARMALABS LIMITED: Q4 2024 Earnings Release
13/05/2024 SHIONOGI & CO., LTD.: Q4 2023 Earnings Release
13/05/2024 MOCHIDA PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
13/05/2024 SAWAI GROUP HOLDINGS CO., LTD.: Q4 2023 Earnings Release
13/05/2024 MEGA LIFESCIENCES: Q1 2024 Earnings Release
13/05/2024 ALMIRALL, S.A.: Q1 2024 Earnings Release
13/05/2024 JW PHARMACEUTICAL CORPORATION: Q1 2024 Earnings Release (Projected)
13/05/2024 DONGKOOK PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release (Projected)
13/05/2024 GREEN CROSS HOLDINGS CORPORATION: Q1 2024 Earnings Release (Projected)
More events

Past sector events for EntreMed Inc

10/05/2024 04:20 pm ANI PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
10/05/2024 PIRAMAL PHARMA LIMITED: Q4 2024 Earnings Release
10/05/2024 NEULAND LABORATORIES LIMITED: Q4 2024 Earnings Release
10/05/2024 NIPPON SHINYAKU CO., LTD.: Q4 2023 Earnings Release
10/05/2024 ROHTO PHARMACEUTICAL CO.,LTD.: Q4 2023 Earnings Release (Projected)
10/05/2024 KYORIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
10/05/2024 JCR PHARMACEUTICALS CO., LTD.: Q4 2023 Earnings Release
10/05/2024 TTY BIOPHARM COMPANY LIMITED: Q1 2024 Earnings Release (Projected)
09/05/2024 07:28 pm SCINOPHARM TAIWAN, LTD.: April 2024 Sales and Revenue Release
09/05/2024 06:36 pm ABBOTT INDIA LIMITED: Q4 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. CASI Stock
  4. Stock
  5. Calendar EntreMed Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW